Hongmei Hongmei Xu
Seminars
Wednesday 18th November 2026
Optimizing Bicycle Drug Conjugate Dosage Using Exposure-Response Data
12:00 pm
- Developing Pop-PK and Exposure-Response models to identify patient characteristics that could impact PK of Bicycle Drug Conjugates® (BDC)
- Integrating PK, efficacy, and safety data to characterise risk-benefit profile and identify optimal dosing strategies
- Establishing a modelling platform to support BDC® decision making in drug development
